-
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Teaming Up for Better Treatment
Across the country, survivors' opinions and actions are influencing cancer care.
by Stephen Ornes
-
Forward Look
Diagnosis: DebtEven for the insured, cancer care can be a financial burden.
by Jocelyn Selim
-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Stranger in a Strange Land
Cancer puts everyone in foreign territory, but those diagnosed with a rare form of the disease may feel the most lost without clear guidance toward the best care or support from other survivors. Four steps can help ease the way.
by Rabiya S. Tuma
-
Forward Look
Task Force Says “No” to PSA for Prostate Cancer ScreeningExpert panel's recommendation spurs debate.
by Stephen Ornes
-
Forward Look
The Dense Breast DebateSome states are mandating that doctors tell patients about breast density, which can affect cancer risk.
by Mitzi Baker
-
Q&A
Facing the CriticsRoger Ebert finds peace with his appearance following disfiguring cancer surgery.
by Ronni Gordon
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
Cancer Talk
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons